Taysha Gene Therapies, Inc.
Taysha Gene Therapies, Inc. (TSHA) Stock Overview
Key statistics and deep links to earnings, valuation, revenue, dividends, and more.
FMP · TSHA · as of Jun 8, 2026
Key Statistics
Explore Taysha Gene Therapies, Inc. Data
tsha stock data · financialsFinancial Snapshot
Full FinancialsAnalyst Ratings & Price Target
Full ForecastTotal: 16 · Buy rate: 75.0%
The TSHA analyst consensus is Buy, based on ratings from 16 Wall Street analysts over the past 3 months. The average 12-month price target is $12.00, representing +123.07% upside from the current price of $5.38.
Competitors & Peers
tsha competitorsTSHA
ANAB
ATAI
BBOT
DNTH
ELVNStock Performance
Full HistoryAbout Taysha Gene Therapies, Inc.
Taysha Gene Therapies, Inc. is a biotech firm specializing in the creation and market introduction of gene therapies that utilize adeno-associated virus (AAV) vectors. Its core mission is to tackle in…
what is taysha gene therapies, inc. · tsha stock overview · taysha gene therapies, inc. company profile · who is taysha gene therapies, inc. ceo · tsha NASDAQ · taysha gene therapies, inc. headquarters · taysha gene therapies, inc. business segments
About Stock Overview & Key Data
Taysha Gene Therapies, Inc. (TSHA) is a Healthcare company in the Biotechnology industry, listed on NASDAQ since Sep 24, 2020. As of the latest trading session, TSHA stock price is $5.38, with a market capitalization of $1.4B. The stock has returned +93.93% over the past 12 months and -1.27% year-to-date.
According to 16 Wall Street analysts, the consensus rating for Taysha Gene Therapies, Inc. stock is Buy, with an average 12-month price target of $12.00. In fiscal year 2025, Taysha Gene Therapies, Inc. reported revenue of $9.8M and net income of -$109.0M. For detailed data — including Taysha Gene Therapies, Inc. revenue history, earnings, dividends, and PE ratio — use the tabs above.
Frequently Asked Questions
As of the latest trading session, Taysha Gene Therapies, Inc. (TSHA) stock price is $5.38. The stock is traded on NASDAQ under the ticker symbol TSHA. The 52-week range is $2.25 – $7.30.